A Non-interventional, Observational Study for Quality of Life (Overall Health Assessment) in Patients With Chronic Severe Pain During Targinact® Treatment

UnknownOBSERVATIONAL
Enrollment

1,800

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

November 30, 2013

Study Completion Date

January 31, 2014

Conditions
Chronic Severe Pain
Interventions
DRUG

Targinact® (oxycodon/naloxon)

Trial Locations (1)

Unknown

RECRUITING

University Hospital Brussels (UZ Brussel), Belgium, Brussels

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Mundipharma CVA

OTHER